HB 598 creates a temporary license for internationally trained physicians to practice medicine in Maryland under specific conditions. It allows the State Board of Physicians to issue a 3-year license (non-renewable) to doctors who hold a WHO-recognized medical degree outside the U.S., completed 2 years of equivalent postgraduate training, practiced medicine for 5 of the last 7 years abroad, passed U.S. medical exams (USMLE Steps 1-3), and meet other criteria like English proficiency and Maryland residency. The license requires physicians to pursue full licensure through board-established pathways after the temporary period ends. This directly affects internationally trained doctors seeking to work in Maryland’s healthcare system, providing a structured but limited pathway to practice.
SB 489 modifies Maryland's licensing rules for physicians trained at international medical schools. It exempts applicants who provide evidence of completing two years of postgraduate training accredited by ACGME-I or another board-recognized body from standard educational requirements. These physicians would be permitted to practice medicine only during their initial license term under mandatory supervision, as specified by the Board. The bill takes effect October 1, 2026, directly affecting international medical graduates meeting these specific training criteria.
HB 813 authorizes Maryland's Medicaid program (Maryland Medical Assistance Program) to cover comprehensive obesity treatment, including intensive behavioral therapy, bariatric surgery, and FDA-approved weight management medications, starting January 1, 2027. The bill requires the Maryland Department of Health to notify Medicaid recipients if it chooses to provide this coverage and mandates a report to the legislature by November 1, 2027, on implementation progress. This directly affects Medicaid recipients with obesity by expanding covered treatments beyond current scope. The program may use standard utilization management processes (like for other conditions) to assess medical necessity but is not required to offer the coverage.
This bill updates Maryland's newborn screening program by changing how fees are set and how new tests are added to the screening panel. It requires the Department of Health to charge fees that cover all administrative, laboratory, and follow-up costs rather than setting a specific maximum amount. The bill also establishes a process where an advisory council must review risks, costs, and accessibility before the department decides whether to test for new conditions added to the national screening panel. Additionally, it extends the timeline for implementing new tests to two years if equipment or supplies are delayed, with required reporting to state committees.
HB 921 limits when minors in Maryland juvenile facilities can be placed in restrictive housing (isolation or special confinement). It prohibits using restrictive housing for discipline, punishment, or staff convenience, and requires facilities to use it only for immediate safety risks (like harm to self/others or facility security) for the shortest time possible (max 6 hours). Minors can request restrictive housing or withdraw that request at any time, and facilities must provide mental health screenings within 1 hour of placement. The bill also mandates that minors in restrictive housing receive the same access to phone calls, visits, medical care, education, and recreation as other minors, unless safety is at risk.
HB 1617 establishes "Health Innovation Zones" in Maryland counties to address health disparities. It defines zones as areas with documented health gaps (like high maternal complications, chronic diseases, or low access to care) in communities of color, low-income areas, or immigrant populations. Counties must create incentives for grocery stores, pharmacies, and healthcare providers to locate in these zones, and Prince George’s County must designate specific zones (including the Blue Line Corridor and areas near DC) while seeking additional zones meeting the same criteria. The bill requires annual $5 million state funding starting in 2028 for the Maryland Economic Development Corporation to support these businesses and exempts them from local zoning laws within designated zones.
HB 1143 bans the use of the "lung float test" (a hydrostatic lung test) during perinatal autopsies in Maryland. It directly affects the Chief Medical Examiner, deputy examiners, assistant examiners, and authorized pathologists when determining if a death was a stillbirth or occurred after a live birth. The bill prohibits this specific test method and allows parents, guardians, or legal representatives to file a civil lawsuit if the test is used unlawfully. Violations also become grounds for disciplinary action against medical examiners.
HB 1150 expands pharmacists' scope of practice in Maryland to prescribe, administer, and dispense medications for specific minor conditions and HIV prevention/treatment under statewide protocols. It directly affects pharmacists (by allowing new clinical duties) and patients (by increasing access to care for conditions like cold sores, strep throat, flu, lice, urinary infections, and HIV testing). Key provisions include permitting pharmacists to prescribe for minor, self-limiting conditions without a new diagnosis and to perform/interpret HIV lab tests while prescribing PrEP/PEP medications. The bill repeals the previous nPEP standing order program and requires the Maryland Department of Health to establish these protocols.
HB 1325 authorizes licensed clinical social workers to evaluate permanent impairments involving behavioral or mental disorders in Maryland workers' compensation claims. It requires these social workers to meet specific qualifications, including training in mental/behavioral conditions, rehabilitation counseling registration, two years of post-licensure experience, and COMAR authorization. The bill directly affects workers seeking compensation for mental/behavioral impairments and licensed clinical social workers who wish to provide these evaluations. It amends Maryland’s workers’ compensation law (Article 9, Section 9-721) to expand evaluation eligibility beyond psychologists and physicians. The changes take effect October 1, 2026.
HB 1048 requires Maryland chain restaurants with 20 or more locations to display warning icons next to menu items containing high sodium (1,150mg+ per serving) or high added sugars (25mg+ per serving) starting January 1, 2028. The Maryland Department of Health must adopt regulations by January 2027 establishing the icon designs, minimum sizes, and accompanying text. The bill also mandates a 2027 public education campaign to help restaurants comply with the new requirements. This directly affects large chain restaurants operating in Maryland, aiming to increase consumer awareness of nutritional content in menu items.
